Biosensors Market Size, Share, Trends, Growth and Forecast 2032

Biosensors Market

Biosensors Market: by Application (Medical, Food Toxicity, Bioreactor, Agriculture, Environment and Others) by Technology (Thermal, Electrochemical, Piezoelectric, Optical) by End Use (Home Healthcare Diagnostics, PoC Testing, Food Industry, Research Laboratories, Security & Bio-defense) Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032

Category: Semiconductor & Electronics Report Format : PDF Pages: 200 Report Code: ZMR-4908 Published Date: Sep-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 28.68 Billion USD 60.26 Billion 8.6% 2023

The global Biosensors Market size was worth around USD 28.68 Billion in 2023 and is predicted to grow to around USD 60.26 Billion by 2032 with a compound annual growth rate (CAGR) of roughly 8.6% between 2024 and 2032.

Biosensor is a device which is used to detect the concentration or presence of biological analyte, like a biological structure or a microorganism. These sensors consist of a component which recognizes the analyte & produces a signal, a reader device and a signal transducer.

Global Biosensors Market SizeRequest Free Sample

Biosensors Market: Definition/Overview

Biosensors are utilized for identifying analytes, consisting of a biological element and a physiochemical detector. They mainly consist of three parts: an analyte-identifying component that generates a signal, a signal transducer, and a reader device. The biosensor reader device is combined with associated electronics or signal processors, which are primarily responsible for displaying results in a user-friendly manner.

Biosensors can be utilized for monitoring the presence of products, biomass, enzymes, antibodies, or process by-products to indirectly measure process conditions. They effectively manage the foaming industry and yield reproducible outcomes due to their simple instrumentation, strong selectivity, affordability, and ease of automation. Biosensors are also widely employed in the medical field for diagnosing communicable diseases.

The market for biosensors is attributed to witness growth in the long run. The demand for miniature diagnostic devices, surging scope of application of wearable devices in medical industry and rapid technological advancements in biosensors is expected to boost market growth. The increasing unhealthy lifestyle, rising chronic diseases along with early and precise diagnosis of diseases is anticipated to propel market growth in the long run. Moreover, in the recent past, the increasing demand for cost-efficient, user-friendly and disposable devices with fast response has increased. Owing to the requirement of accurate and timely diagnosis of disease to successful operation them is anticipated to propel growth.

What Factors are Driving the Growth of the Biosensors Market?

Increasing demand for accurate and rapid detection methods across various industries is being witnessed. This demand is being driven by the need for precise diagnostics in medical applications, stringent regulations in food safety, and the imperative for environmental monitoring.

Additionally, Innovations in electrochemical, optical, and thermal techniques contribute to enhancing the performance and versatility of biosensors. These technological advancements enable biosensors to offer improved sensitivity, selectivity, and reliability, thereby widening their applicability across diverse sectors.

Regulatory bodies are emphasizing the importance of reliable detection methods in ensuring public health and safety, which further drives the demand for biosensors in various applications. Moreover, increasing investments in research and development activities fuel innovation in biosensor design and functionality. Funding support from governments, private organizations, and academic institutions enables the exploration of novel materials, sensing mechanisms, and miniaturization techniques, driving the evolution of biosensors. The growing prevalence of chronic diseases and infectious illnesses worldwide also contributes to the expansion of the biosensors market. Biosensors play a crucial role in medical diagnostics by enabling the rapid and accurate detection of biomarkers associated with diseases, facilitating early intervention and treatment.

Furthermore, the trend towards personalized medicine and point-of-care testing further accelerates the adoption of biosensors in healthcare settings. Biosensors offer the potential for decentralized testing, allowing for timely diagnosis and monitoring of patients outside traditional laboratory settings. Increasing awareness regarding environmental conservation and sustainability drives the demand for biosensors in environmental monitoring applications. Biosensors enable real-time detection of pollutants and contaminants, aiding in the preservation of ecosystems and ensuring compliance with environmental regulations.

Additionally, miniaturization of these biosensors have changed the conventional testing scenario healthcare and in medical sectors. Medical biosensors are used to diagnose blood glucose monitoring, cholesterol testing, drug discovery, pregnancy testing systems and infectious diseases. These sensors are considered to be a vital tool in the monitoring and detection of large variety medical situations such as cancer and diabetes.

The use of biosensors in agriculture to provide specific and rapid detection of numerous funguses as compared to the older techniques is anticipated to foster growth for biosensors in the forecast time frame. These sensors are adopted to diminish the loss of crops and livestock by bioterrorism and natural threats. The dives are also used to measure pesticides concentrations, herbicides and heavy metals. It can also be used to forecast the occurrence of soil disease, which is not possible with current technology and therefore it providing advanced and reliable ways for prevention and decontamination of soil disease at the initial phase. factors like these are likely to contribute market growth.

Biosensors Market: Segmentation

The study provides a decisive view of the Biosensors Market by segmenting the market based on by application, by technology, By end use and by region.

By Application, the Biosensors Market is segmented into medical food toxicity, bioreactor, agriculture, Environment and others.

By end use- the into Home Healthcare Diagnostics, PoC Testing, Food Industry, Research Laboratories and Security & Bio-defense. PoC Testing biosensor had a significant market share in 2023.

By the technology related to original product developments like ultrasensitive printable biosensors for PoC application to help in monitoring biological fluids like blood, urine, saliva and sweat are among significant drivers are key rendering drivers attributing to the growth of biosensors in point of care diagnostics market over the forecast period 2024 to 2032.

On the basis of geography, Asia pacific is anticipated to unveil the significant growth opportunity during the forecast period. Due to the presence of unmet medical needs relating to target disease like diabetes and cancer along with other infectious diseases and continuously improving healthcare expenditure in the region, are some factors likely to support market growth of Asia Pacific market.

Biosensors Market: Report Scope

Report Attributes Report Details
Report Name Biosensors Market
Market Size in 2023 USD 28.68 Billion
Market Forecast in 2032 USD 60.26 Billion
Growth Rate CAGR of 8.6%
Number of Pages 200
Key Companies Covered Infosys,TCS , Medtronic Inc., IBM, Universal Biosensors Inc., LifeScan Inc, DuPont , Abbott Point of Care Inc., Pharmaco-Kinesis Corporation and LifeSensors Inc. among others
Segments Covered By Application, By Technology, By End Use and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Prominent Global biosensors market players such as Infosys,TCS ,  Medtronic Inc., IBM, Universal Biosensors Inc., LifeScan Inc, DuPont , Abbott Point of Care Inc., Pharmaco-Kinesis Corporation and LifeSensors Inc. among others

The report segments automotive global biosensors market as follows:

Global Biosensors Market: Application Segment Analysis

  • Medical
  • Food Toxicity
  • Bioreactor
  • Agriculture
  • Environment
  • Others

Global Biosensors Market: Technology Segment Analysis

  • Thermal
  • Electrochemical
  • Piezoelectric
  • Optical

Global Biosensors Market: End Use Segment Analysis

  • Home Healthcare Diagnostics
  • PoC Testing
  • Food Industry
  • Research Laboratories
  • Security & Bio-defense

Global Biosensors Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Biosensors are utilized for identifying analytes, consisting of a biological element and a physiochemical detector. They mainly consist of three parts: an analyte-identifying component that generates a signal, a signal transducer, and a reader device. The biosensor reader device is combined with associated electronics or signal processors, which are primarily responsible for displaying results in a user-friendly manner.

The Biosensors Market was valued at USD 28.68 Billion in 2023.

The Biosensors Market is expected to reach USD 60.26 Billion by 2032, growing at a CAGR of 8.6% between 2024 to 2032.

Increasing demand for accurate and rapid detection methods across various industries is being witnessed. This demand is being driven by the need for precise diagnostics in medical applications, stringent regulations in food safety, and the imperative for environmental monitoring.

Prominent Global biosensors market players such as Infosys, TCS, Medtronic Inc., IBM, Universal Biosensors Inc., LifeScan Inc, DuPont, Abbott Point of Care Inc., Pharmaco-Kinesis Corporation and LifeSensors Inc. among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed